Hers vs Wellorithm: Which GLP-1 Provider Is Better?
Short answer: Wellorithm scores higher on our rubric, 7.4/10 against 5.3/10. Full reasoning, pricing and the cases where the other one wins are below.
Wellorithm beats Hers overall, scoring 7.4/10 vs 5.3/10. Published pricing is not a like-for-like monthly comparison: Hers is $188 first month, then $298/mo; Wellorithm is from $147/mo. Choose Hers for women who want a female-focused platform and can budget at least $188 initially and $298/mo ongoing for a $149 medication path. Choose Wellorithm for cash-pay patients who want compounded semaglutide or tirzepatide in a rare oral dissolving tablet format, backed by a 10% weight-loss money-back guarantee and 24/7 support.
A side-by-side look at Hers and Wellorithm to help you decide. We compare them on:
- •Starting price per month
- •Our overall score, out of 10
- •Medication type, brand-name or compounded
- •Whether they accept insurance
- •Who each one is best for
Hers
#26 of 34The women's health arm of Hims & Hers Health (NYSE: HIMS). Hers lists Wegovy pill, Foundayo, and Ozempic pill medication from $149, a Wegovy pen from $199, Zepbound from $299, and compounded options. Wegovy and Foundayo carry FDA approval for weight management. Ozempic is FDA approved for type 2 diabetes and is prescribed off label for weight loss. A required Weight Loss Membership adds $39 in month one and $149/mo thereafter, so the all-in floor for a $149 medication path is $188 initially and $298/mo ongoing; exact product and dose prices vary.
Visit HersWellorithm
#13 of 34Telehealth platform offering compounded semaglutide and tirzepatide in BOTH injectable and oral dissolving tablet formats, alongside brand-name Wegovy, Ozempic, Zepbound and Mounjaro on their own product pages, plus NAD+ and Sermorelin on the same pricing grid (verified 2026-09-03). A 10% weight-loss guarantee refunds up to four months of program fees if the patient does not lose at least 10% of baseline weight after 16 weeks of medication adherence (terms apply). 28-day recurring billing, non-refundable per-cycle.
Visit Wellorithm| Feature | Hers | Wellorithm |
|---|---|---|
| Why each one | A major women-focused telehealth platform with a direct Novo Nordisk partnership (Wegovy pill from $149 and pen from $199 before required membership) and a Lilly partnership (Zepbound medication from $299) alongside compounded options. | The combination of compounded GLP-1 in BOTH injectable and oral dissolving tablet formats AND a 10% weight-loss money-back guarantee, a format breadth and outcome-tied refund policy that few compounded-only platforms offer in combination, paired with the trade-off that no founder or legal entity is named on the site. |
| Our Score | 5.3/10 | 7.4/10 |
| Headline Price | $188 first month, then $298/mo | from $147/mo |
| Medication Type | Both | Both |
| Insurance Accepted | No | No |
| Best For | Women who want a female-focused platform and can budget at least $188 initially and $298/mo ongoing for a $149 medication path | Cash-pay patients who want compounded semaglutide or tirzepatide in a rare oral dissolving tablet format, backed by a 10% weight-loss money-back guarantee and 24/7 support |
| Watch out for | Pending federal enforcement against the parent company: on July 29, 2026 the FTC, joined by Utah and by California acting through Los Angeles County Counsel, sued Hims & Hers Health, Inc. in the Northern District of California over subscription billing, cancellation friction and sharing consumer health information with advertising platforms. The case status is Pending and these are allegations, not findings (checked 2026-09-03). | Founding year, corporate ownership and the legal entity behind the program are not published on wellorithm.com; the Terms describe it only as 'a Miami-based company' that connects patients with unnamed 'Professional Entities' (verified 2026-09-03). The program page and every medication page do name three partner physicians, and the contact page gives a Miami street address and phone, so the gap is corporate rather than clinical |
| Ranking | #26 | #13 |
| Get started | Visit Hers | Visit Wellorithm |
Pros & Cons Compared
Hers
Pros
- +Brand-name paths include Wegovy pill, Foundayo, and Ozempic pill medication from $149 and a Wegovy pen from $199. Wegovy and Foundayo carry FDA approval for weight management, Ozempic is approved for type 2 diabetes and is used off label here. With the required membership, a $149 medication path totals $188 initially and $298/mo ongoing
- +Zepbound access via the Lilly/Hims-Hers partnership announced 2026
- +Publicly traded company (NYSE: HIMS) with strong financial backing and regulatory compliance
- +Broader women's health platform, integrates weight loss with hormonal, skin, and wellness services
Cons
- −Pending federal enforcement against the parent company: on July 29, 2026 the FTC, joined by Utah and by California acting through Los Angeles County Counsel, sued Hims & Hers Health, Inc. in the Northern District of California over subscription billing, cancellation friction and sharing consumer health information with advertising platforms. The case status is Pending and these are allegations, not findings (checked 2026-09-03).
- −Every medication figure excludes the required Weight Loss Membership ($39 first month, then $149/mo); exact product and dose prices can increase the total above the $188/$298 floor
- −Support runs at big-platform scale, fine for routine refills, less personal if you want high-touch care
- −Compounded pricing starts at $199/mo with stepped pricing at higher doses, budget for the dose you'll end up on, not the entry dose
- −Zepbound medication starts at $299 before the required membership; that path totals $338 in month one and at least $448/mo ongoing, with exact dose pricing potentially higher
Wellorithm
Pros
- +Compounded GLP-1 available in BOTH injectable AND oral dissolving tablet formats, semaglutide and tirzepatide each in two formats, broader format menu than most compounded-only platforms
- +10% weight-loss money-back guarantee: patients who don't lose at least 10% of baseline weight after 16 weeks of medication adherence may be eligible for refund of up to four months of program fees (verified weight documentation required)
- +Competitive entry pricing, $147/mo compounded semaglutide and $249/mo compounded tirzepatide put Wellorithm near the cheaper end of the compounded market
- +Short online eligibility quiz, virtual consultation, 24/7 support availability claimed
- +23,000+ reviews and 4.9-star rating reported (volume is unusually high for this market segment, verify on independent third-party sources before relying on it)
- +Spring promotion advertised at $147 with free shipping included
Cons
- −Founding year, corporate ownership and the legal entity behind the program are not published on wellorithm.com; the Terms describe it only as 'a Miami-based company' that connects patients with unnamed 'Professional Entities' (verified 2026-09-03). The program page and every medication page do name three partner physicians, and the contact page gives a Miami street address and phone, so the gap is corporate rather than clinical
- −49 states only, service is unavailable in Louisiana and outside the United States
- −Billing runs on a 28-day recurring cycle and payments are non-refundable once processed, with no proration for partial months; cancel before your next cycle processes to avoid paying for an unused month
- −The weight-loss guarantee has strict eligibility terms: verified weight documentation (doctor attestation or video evidence), prior medication history disclosure, consistent dosing adherence, and refund processed within 30 days of approval, with only fees actually paid refundable and baseline payments non-refundable; document your starting weight from day one if you plan to rely on it
- −Brand-name prices carry conditions the headline figures do not show: the Ozempic and Zepbound pages advertise $1,119 a month at the top and $1,199 a month in the pricing card, and all four brand pages footnote that the figure applies to a 500mg three-month plan paid upfront or through a buy now, pay later program (verified 2026-09-03). Budget for the prepaid plan, not the monthly number
Our Verdict
Wellorithm edges out Hers with a score of 7.4/10 vs 5.3/10. Published pricing is not a like-for-like monthly comparison: Hers is $188 first month, then $298/mo; Wellorithm is from $147/mo.
Reviews and pricing sources
Related comparisons
More head-to-head comparisons involving Hers and Wellorithm.
Not comparing, just asking? Quick answers to the most-asked GLP-1 questions →
- Compare Hers and Enhance MDfrom $212/mo
- Compare Hers and Direct Meds GLP-1from $297/mo
- Compare Hers and PeterMDfrom $149/mo
- Compare Wellorithm and Direct Meds GLP-1from $297/mo
- Compare Wellorithm and Embodyfrom $69/mo
- Compare Wellorithm and MangoRxfrom $299/mo
Not sure which one is right for you?
Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.
Still working out whether either one is above board? We check that separately: is Hers legit and is Wellorithm legit, with the verification evidence behind each answer.
Our pick of these two: Wellorithm · 7.4/10